Correlation Between Acumen Pharmaceuticals and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Emergent Biosolutions, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Emergent Biosolutions.
Diversification Opportunities for Acumen Pharmaceuticals and Emergent Biosolutions
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Acumen and Emergent is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Emergent Biosolutions
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Emergent Biosolutions. But the stock apears to be less risky and, when comparing its historical volatility, Acumen Pharmaceuticals is 1.4 times less risky than Emergent Biosolutions. The stock trades about -0.2 of its potential returns per unit of risk. The Emergent Biosolutions is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 877.00 in Emergent Biosolutions on September 3, 2024 and sell it today you would earn a total of 135.00 from holding Emergent Biosolutions or generate 15.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Emergent Biosolutions
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Emergent Biosolutions |
Acumen Pharmaceuticals and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Emergent Biosolutions
The main advantage of trading using opposite Acumen Pharmaceuticals and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.| Acumen Pharmaceuticals vs. DiaMedica Therapeutics | Acumen Pharmaceuticals vs. Lyra Therapeutics | Acumen Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
| Emergent Biosolutions vs. Connect Biopharma Holdings | Emergent Biosolutions vs. Acumen Pharmaceuticals | Emergent Biosolutions vs. Nuvation Bio | Emergent Biosolutions vs. Eledon Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |